Updating the progress of Argos’ dendritic cell immunotherapies in development to treat cancer, infectious and autoimmune diseases


Guest: Jeffrey Abbey, President & CEO, Argos Therapeutics, Inc., Durham, NC

abbey2010photo.jpg
Jeffrey Abbey, President & CEO, Argos Therapeutics, Inc., Durham

Argos Therapeutics, Inc.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s